Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ultragenyx Pharmaceutical Inc (RARE)  
$41.40 0.37 (0.89%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 82,110,000
Market Cap: 3.40(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.73 - $53.69
Level I Sector: Consumer Discretionary
Level II Sector: Leisure
Level III Sector: Restaurants

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    NASDAQ INDUSTRIAL     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,005 99,487 197,241 249,694
Total Sell Value $596,362 $4,824,734 $8,130,065 $10,494,293
Total People Sold 2 8 9 12
Total Sell Transactions 3 12 19 35
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 628
  Page 25 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Aliski William Director   –       •      –    2014-12-04 4 S $41.83 $252,942 D/D (6,000) 60,010     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2014-11-20 4 AS $44.07 $176,281 D/D (4,000) 68,255     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2014-11-12 4 AS $41.85 $139,486 D/D (3,333) 95,805     -
   Aliski William Director   –       •      –    2014-10-20 4 OE $3.01 $87,615 D/D 29,108 66,010     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2014-10-20 4 AS $46.02 $184,080 D/D (4,000) 72,255     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2014-10-08 4 AS $53.26 $177,516 D/D (3,333) 99,138     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2014-09-18 4 AS $56.00 $224,000 D/D (4,000) 76,255     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2014-09-10 4 AS $54.82 $182,715 D/D (3,333) 102,471     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2014-09-03 4 AS $55.00 $550,000 D/D (10,000) 105,804     -
   Kassberg Thomas Richard CBO & Senior Vice President   •       –      –    2014-09-02 4 AS $52.82 $528,200 D/D (10,000) 115,804     -
   Agarwal Sunil Chief Medical Officer   •       –      –    2014-08-19 4 A $0.00 $0 D/D 25,000 25,000     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2014-08-18 4 AS $53.97 $215,880 D/D (4,000) 80,255     -
   Fmr Corp See Remark 1.   –       –      –    2014-08-01 4 D $0.00 $0 I/I (1,802,246) 1,457,994     -
   Coulter James G Former 10% Owner (2)(3)(4)(5)   –       –      –    2014-07-14 4 S $37.60 $18,379,632 I/I (488,820) 2,596,420     -
   Aliski William Director   –       •      –    2014-02-05 4 A $0.00 $0 I/I 84,970 121,900     -
   Kassberg Thomas Richard Chief Business Officer & SVP   •       –      –    2014-02-05 4 A $0.00 $0 D/D 31,454 125,804     -
   Kakkis Emil D President & CEO   •       •       •   2014-02-05 4 A $0.00 $0 D/D 624,240 624,240     -
   Coulter James G 10% Owner   –       –       •   2014-02-05 4 A $0.00 $0 I/I 3,085,240 3,085,240     -
   Fmr Corp Edward C. Johnson 3d   –       –       •   2014-01-31 4 B $21.00 $3,675,000 I/I 175,000 3,260,240 1.5     -
   Fmr Corp Edward C. Johnson 3d   –       –       •   2014-01-30 4 A $0.00 $0 I/I 3,085,240 3,085,240     -
   Sharp Shalini CFO & Senior Vice President   •       –      –    2014-01-30 4 B $21.00 $94,500 D/D 4,500 84,255 2.74     -
   Fust Matthew K Director   –       •      –    2014-01-30 4 B $21.00 $105,000 D/D 5,000 5,000 2.39     -
   Kassberg Thomas Richard Chief Business Officer & SVP   •       –      –    2014-01-30 4 B $21.00 $31,500 D/D 1,500 94,350 2.74     -
   Aliski William Director   –       •      –    2014-01-30 4 B $21.00 $105,000 D/D 5,000 36,903 2.39     -
   Kakkis Emil D See RemarksOfficer   •       •       •   2014-01-30 3 IO $0.00 $0 I/I 0 2,552,241     -
  628 Records found
  Previous  20  21  22  23  24  25  26   
  Page 25 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us